New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2013
07:32 EDTHZNPHorizon Pharma gets U.K. marketing authorization for DUEXIS
Horizon Pharma announced that the United Kingdom Medicines and Healthcare products Regulatory Agency has granted marketing authorization for DUEXIS for the symptomatic treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who require regular treatment with high dose ibuprofen administered three times a day and who are at risk of developing non-steroidal anti-inflammatory drug associated gastric and/or duodenal ulcers. Horizon is seeking to license rights to DUEXIS in Europe to one or more commercial partners.
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
07:45 EDTHZNPHorizon Pharma price target raised to $27 from $18 at Brean Capital
Subscribe for More Information
February 27, 2015
14:38 EDTHZNPHorizon Pharma price target raised to $30 from $24 at Avondale
09:24 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
07:12 EDTHZNPHorizon Pharma raises FY15 revenue guidance to $450M-$475M from $425M-$450M
Subscribe for More Information
07:10 EDTHZNPHorizon Pharma reports Q4 adjusted EPS 27c, consensus 22c
Reports Q4 revenue $103.8M, consensus $95.54M.
February 20, 2015
10:20 EDTHZNPHigh option volume stocks
Subscribe for More Information
07:08 EDTHZNPAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use